<DOC>
	<DOCNO>NCT00639678</DOCNO>
	<brief_summary>To evaluate safety tolerability raxibacumab healthy subject .</brief_summary>
	<brief_title>A Study Evaluate Safety Tolerability Raxibacumab Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Key Male female , 18 year age old Normal laboratory ( blood test ) result Subjects eligible enter study pregnant nursing , sterile nonchildbearing potential , willing practice abstinence use appropriate birth control method study ( 2 month ) Key History significant , acute chronic disease ( ie , heart , lung , gastrointestinal , liver , kidney , neurological infectious disease ) . Prior immunization anthrax vaccine adsorb ( AVA ) , prior treatment investigational anthrax therapy , prior treatment anthrax exposure , prior anthrax infection . History Type I hypersensitivity reaction food drug , IV contrast agent , antihistamine , history hive . A current drug alcohol addiction . Positive human immunodeficiency virus ( HIV1 ) , Hepatitis B surface antigen , Hepatitis C antibody . Cancer within last 5 year ( exception adequately treat basal cell carcinoma skin situ carcinoma cervix ) . Participation within 60 day intiating study refusal refrain participation study clinical trial investigational compound . Previous exposure raxibacumab .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>healthy volunteer</keyword>
</DOC>